Siripanthong Bhurint, Asatryan Babken, Hanff Thomas C, Chatha Salman R, Khanji Mohammed Y, Ricci Fabrizio, Muser Daniele, Ferrari Victor A, Nazarian Saman, Santangeli Pasquale, Deo Rajat, Cooper Leslie T, Mohiddin Saidi A, Chahal C Anwar A
School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
JACC Basic Transl Sci. 2022 Mar;7(3):294-308. doi: 10.1016/j.jacbts.2021.10.011. Epub 2022 Feb 9.
The mechanisms of coronavirus disease-2019 (COVID-19)-related myocardial injury comprise both direct viral invasion and indirect (hypercoagulability and immune-mediated) cellular injuries. Some patients with COVID-19 cardiac involvement have poor clinical outcomes, with preliminary data suggesting long-term structural and functional changes. These include persistent myocardial fibrosis, edema, and intraventricular thrombi with embolic events, while functionally, the left ventricle is enlarged, with a reduced ejection fraction and new-onset arrhythmias reported in a number of patients. Myocarditis post-COVID-19 vaccination is rare but more common among young male patients. Larger studies, including prospective data from biobanks, will be useful in expanding these early findings and determining their validity.
2019冠状病毒病(COVID-19)相关心肌损伤的机制包括直接病毒侵袭和间接(高凝状态及免疫介导)细胞损伤。一些合并心脏受累的COVID-19患者临床结局不佳,初步数据提示存在长期结构和功能改变。这些改变包括持续性心肌纤维化、水肿以及伴有栓塞事件的心室内血栓形成,而在功能方面,左心室扩大,一些患者出现射血分数降低和新发心律失常。COVID-19疫苗接种后发生的心肌炎较为罕见,但在年轻男性患者中更为常见。纳入生物样本库前瞻性数据的更大规模研究,将有助于拓展这些早期发现并确定其有效性。